Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes

Hepatocellular carcinoma (HCC), a highly aggressive tumor, has high incidence and mortality rates. Recently, immunotherapies have been shown to be a promising treatment in HCC. The results of either the CheckMate-040 or IMbrave 150 trials demonstrate the importance of immunotherapy in the systemic t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiahao, Ma, Shuoyi, Tian, Siyuan, Zhang, Miao, Ding, Xiaopeng, Liu, Yansheng, Yang, Fangfang, Hu, Yinan, Xuan, Guoyun, Zhou, Xinmin, Wang, Jingbo, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520962/
https://www.ncbi.nlm.nih.gov/pubmed/34671598
http://dx.doi.org/10.3389/fcell.2021.700553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520962/
https://www.ncbi.nlm.nih.gov/pubmed/34671598
http://dx.doi.org/10.3389/fcell.2021.700553

Ejemplares similares